JIANGSU YAHONG MEDITECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.11 CNY | -1.73% |
|
-7.76% | -52.60% |
| 06-25 | Yahong Meditech to Trial Drug Against Amoebae Infection | MT |
| 06-17 | ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JIANGSU YAHONG MEDITECH CO., LTD. | Bio Therapeutic Drugs | -1.73% | -7.76% | -52.60% | -57.13% | - | 401M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- 688176 Stock
- Charts Jiangsu Yahong Meditech Co., Ltd.
- Comparison Chart
